Infectious diseases are caused by microbial invasion. In order to overcome this invasion, the human body utilizes a sophisticated immune system. Disturbance of this well-organized immune system results in the development of serious infectious diseases. It is, therefore, plausible to consider that EDCs may cause the disturbance because disruption of endocrine function seriously affects the immune system. A number of biological mediators, including tumor necrosis factor-a (TNF-a) and nitric oxide (NO) participate in the defense mechanisms, [4] [5] [6] [7] [8] and they are produced by macrophages in response to microbial toxins, such as bacterial endotoxin. Under normal conditions, the human body can tolerate a certain amount of endotoxin challenge, but toxicity is dramatically increased when the body has been exposed to sensitizing agents. 9) A number of chemicals, including estrogen 10) and environmental pollutants [11] [12] [13] [14] [15] [16] have also been reported to enhance the toxicity of endotoxin. Therefore, EDCs may disturb the human immune system by enhancing the toxicity of endotoxin. Thus, we investigated the effect of chemicals suspected of having an endocrine disrupting effect on endotoxin-induced TNF-a and NO productions by mouse macrophages in vitro and ex vivo. In our knowledge, although a number of immunomodulatory effects of EDCs have been reported, this is the first report examined systematically the effect of EDCs on lipopolysaccharide (LPS)-induced activation of macrophages.
MATERIALS AND METHODS

Chemicals
The eighteen chemicals used as EDCs, carbaryl, zineb, b-hexaclorocychlohexane, cis-permethrin, simazine, 2,4-dichlorophenoxy acetic acid, alachlor, 2,4-dichlorophenol, malathion, nitrofen, benzyl n-butyl phthalate, bisphenol A, p-n-nonylphenol, p-n-octylphenol, styrene, tributyltin (IV) chloride, triphenyltin (IV) chloride, and benzophenone, were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Their CAS No. and abbreviations are shown in Table 1 . Those chemicals were selected from the SPEED'98 list. 17) LPS was prepared from Salmonella abortus equi as described previously. 18) Iscove's medium and actinomycin D were obtained from SIGMA (St. Louis, MO, U.S.A.). Recombinant murine interferon (IFN)-g was purchased from Pepro Tech EC LTD. (London, U.K.). Unless otherwise stated, all other chemicals were of reagent grade or suitable chemical purity and obtained from Wako Pure Chemical Industries, Ltd. For the in vitro experiments, the EDCs listed above were dissolved in dimethyl sulfoxide (DMSO) at 100 mg/ml to produce a stock solution, and the stock solution was diluted to the desired concentration with Dulbecco's modified Eagle medium (DMEM) (Invitrogen Co., N.Y., U.S.A.) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen Co.). DMSO had no effect at the concentration used (Յ0.1%). For the ex vivo experiments, the EDCs were dissolved in DMSO at 10 mg/ml and further diluted with corn oil.
Animals and Cell Preparations Female Balb/c mice, 6-10 weeks of age were purchased from Charles River Japan Inc. (Kanagawa, Japan) and acclimated for a minimum of one week prior to use. The mice were handled in accordance with our institutional guidelines. Murine macrophage cell line RAW 264 was purchased from the RIKEN Cell Bank (Tsukuba, Japan) and cultured in DMEM supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin at 37°C in a humidified incubator under a 5% CO 2 atmosphere. TNF-a sensitive murine fibroblast cell line L929 was obtained from the Human Science Research Resources Bank (Tokyo, Japan) and cultured in RPMI 1640 (Invitrogen Co.) supplemented with 10% heatinactivated FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin at 37°C in a humidified incubator under 5% CO 2 atmosphere.
In Vitro Experiments To assess TNF-a production, RAW 264 cells were plated in 24-well plates (1ϫ10 6 cells/ml/well), and 24 h later the cells were washed with PBS twice and treated with one of the EDCs and 10 ng/ml LPS in the culture medium for 4 h. To assess NO production, RAW 264 cells were plated in 96-well plates (5ϫ10 5 cells/0.1 ml/well), and 16 h later the cells were washed with phosphate-buffered saline (PBS) twice and treated with each EDC and 10 ng/ml LPS in phenol red-free culture medium for 24 h. In one experiment, 3-16 EDCs were evaluated at once, and the experiment was repeated several times (shown as n in Table 2 ) independently on different days.
Ex Vivo Experiments Mice (3 mice for each control and EDC groups) were subcutaneously injected with each EDC (1 mg/0.1 ml/mouse). Four EDCs were evaluated at once in one experiment. The mice were sacrificed 24 h later and abdominal macrophages were harvested into Iscove's medium. The cells were washed with PBS and plated in 96-well plates (5ϫ10 5 cells/well). After 3 h, the cells were washed with PBS twice and stimulated with 10 ng/ml LPS in the culture medium for 4 h for the TNF-a measurements or stimulated with 1 or 10 ng/ml LPS plus 1000 U/ml IFN-g in phenol redfree culture medium for 20 h for the NO measurements. This experiment was repeated several times (shown as n in Tables  3 and 4) independently on different days.
Determination of TNF-a a and NO Productions After exposure to the EDCs, the culture supernatants obtained were centrifuged at 2000 rpm for 10 min, and the supernatant obtained was used to measure the TNF-a and NO concentrations. TNF-a production by RAW 264 cells and peritoneal macrophages was determined by using an ELISA kit (Techne Co., U.S.A.) and L929 cytotoxicity assay, respectively. The L929 cytotoxicity assay was performed by the method described previously. 18) Briefly, L929 cells were plated in 96-well plates (5ϫ10 5 cells/0.1 ml/well) and cultured for 24 h. Actinomycin D (final concentration, 2 mg/ml) and a test sample or TNF-a standard were then added. After culturing for 20 h, the cells that survived were stained with crystal violet (50 mg/ml), and the cells that stained were solubilized with an extraction solution (50 mM KH 2 PO 4 , 50% ethanol). The OD of the solution was measured at 550 nm to assess cytotoxicity. NO levels produced by RAW 264 cells and peritoneal macrophages were determined by measuring the nitrite levels of the culture supernatants with Griess reagent. 19) Statistical Analysis The paired Student's t-test was used to evaluate statistical significance. A p-value of less than 0.05 was considered to be significant.
RESULTS
We selected eighteen chemicals (described as EDCs in this study) that are suspected of having endocrine disrupting effects from among agrochemicals (i.e., insecticides, herbicides), industrial chemicals (i.e., plasticizers, resins) and other groups of chemicals (see Table 1 ). Their effects on LPS-induced TNF-a and NO production was first investigated in vitro in a mouse macrophage cell line RAW 264. RAW 264 cells were exposed to 10 mg/ml of each EDC, except ZNB, TBT, and TPT. Crystal violet staining revealed that ZNB, TBT and TPT at 10 mg/ml caused cytotoxicity in RAW 264 cells, therefore, ZNB was used at 1 mg/ml, and TBT and TPT were used at 0.1 mg/ml. Other EDCs at 10 mg/ml did not cause cytotoxicity. The cells were then stimulated with 10 ng/ml LPS, and TNF-a and NO production was measured. Table 2 summarizes the results. The TNF-a and NO levels were expressed as percentages of the values in the absence of any EDCs. None of EDCs them- selves induced TNF-a or NO production. The LPS-induced TNF-a production was inhibited by CAT, NIP, and BBP, and no significant enhancement of production was observed in response to any of the EDCs. NO production was inhibited by NAC, ACL, NNP, OTP, TBT, and TPT, but was enhanced slightly by 2,4-D and BPA. The inhibition of NO production by NAC and ACL was especially marked. None of the other EDCs tested significantly affected their production. The effect of the eighteen EDCs on LPS-induced TNF-a and NO production was also investigated ex vivo in peritoneal macrophages obtained from mice exposed to EDCs. Mice were subcutaneously injected with an EDC (1 mg/ mouse), and peritoneal macrophages were obtained from the mice 1 d later. Macrophages were stimulated with LPS and IFN-g/LPS to induce TNF-a production and NO production, respectively. Tables 3 and 4 summarize the level of TNF-a and NO production. Production is expressed as a percentage of the values in the absence of any EDCs. No TNF-a or NO production was observed in the absence of LPS or IFNg/LPS stimulation. ZNB and ACL enhanced TNF-a production when 1 ng/ml LPS was used, and ACL inhibited NO production at LPS concentrations of both 1 and 10 ng/ml. None of the other EDCs tested significantly affected their production.
DISCUSSION
The toxicity of bacterial endotoxin is dramatically enhanced when the human body has been exposed to sensitizing agents. 9) Since a number of chemicals, including estrogen 10) and environmental pollutants, such as dioxins, 11, 12, [14] [15] [16] lead, 13) and dibenzofuran 14) have been reported to enhance the toxicity of endotoxin, EDCs may increase the toxicity of endotoxin. We therefore investigated the effect of EDCs on LPS-induced TNF-a and NO production by macrophages, because both TNF-a and NO are known to be the major cytotoxic mediators. 20, 21) We selected eighteen agrochemicals and industrial chemicals that are suspected of having endocrime disrupting effects (see Table 1 ). As expected, the EDCs themselves did not induce TNF-a or NO productions, but productions induced by LPS was affected by some EDCs, positively or negatively, depending on the chemical, indicat-
